The Division of Genetics at CHAM, one of the oldest and best known in the country, has provided family-centered care for infants, children and adults with genetic diseases, birth defects and congenital malformations since 1968.
Our team has diagnosed and treated thousands of children with complex, rare and inherited conditions. Through our connection with basic and clinical science researchers at Montefiore and Einstein, we are able to provide state-of-the-art, precision medicine. Many of our patients remain in our care for years, and even decades.
But although we're able to provide cutting-edge, state-of-the-art precision medicine, the core of our mission is the understanding that care must extend not only to the person with the disease, but also to the parents, siblings and extended family members. Our comprehensive care team gets to know our patients and their families intimately, thereby delivering personal, customized, unparalleled care.
The Division is the administrative home for the Center for Congenital Disorders, the Craniofacial Center at CHAM and the Center for Inherited Metabolic Disorders. In addition, our staff direct the Center for Cardiogenetics, the Spina Bifida Center (a component of the Function Clinic), the Dermato-Genetics Program and the Williams Syndrome Center.
The Division is dedicated to providing clinical services, performing clinical and basic science research, and training the next generation of leaders in our field. Our faculty—which forms the core staff for these centers—are actively involved in all of these pursuits.
The NY Center for Rare Diseases at Montefiore Einstein has become one of 40 academic medical centers selected to be part of a national network dedicated to diagnosing, treating, and researching all rare diseases. The network is led by the National Organization for Rare Disorders (NORD) and is designed to foster knowledge sharing between experts across the country to meet the unmet needs of more than 25 million Americans living with a rare disease.
Montefiore Health System was selected for its research and clinical excellence in caring for people with complex, rare and inherited conditions, including its delivery of state-of-the-art precision medicine.